- Anita Burrell
- Adjunct Assistant Professor, Founder Member of The Aurora Project
- Rutgers University, United States
After 23 years of leadership experience in the pharmaceutical industry in a wide variety of roles and geographies as a market access pioneer, Anita left Sanofi to further her interest in improving health outcomes. She is a Founding Member of the Aurora Project which seeks to explore and promote patient centricity in the pharmaceutical industry and hold asn adjunct professor post at the Ernest Mario School of Pharmacy at Rutgers University. Anita has a proven ability to lead change and motivate others. As part of her previous roles she has been responsible for developing value driven processes across marketing, R&D and market access functions. As the Global Project Lead for Aubagio, the oral MS therapy from Genzyme, she was able to bring Aubagio to market over eight months ahead of schedule becoming the second oral therapy to market in the USA and EU. Aubagio is the fastest growing MS product in the US and the #1 product in the Genzyme/Sanofi portfolio with revenue of €1.6B in 2017.
Anita currently works as a consultant in her eponymously named business and has helped companies to:
•Understand market dynamics and payer behavior in diabetes and MS
•Design big data platforms to deliver value in terms of regional sales variations
•Develop predictive models to inform HTA submissions
•Understand the implications of digital health and possibilities to use behavioural economics
Anita holds a BA (Hons) in Economics from the University of Stirling, an M.A. in Economics from Dalhousie University, Nova Scotia, Canada, and a Masters in Business Administration from Kingston University, Surrey UK. She speaks French at an advanced level.